找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Immunology; Cancer Immunotherapy Nima Rezaei Book 20151st edition Springer-Verlag Berlin Heidelberg 2015 Cancer immunology.Cancer im

[復(fù)制鏈接]
樓主: hierarchy
61#
發(fā)表于 2025-4-1 04:31:31 | 只看該作者
Immunopathology of Head and Neck Tumors and Immunotherapy of Squamous Cell Carcinoma,ce has been induced by cytotoxic T lymphocytes (CTLs), specific immune suppression is associated with tumor malignancy and progression. This contributes to unsatisfactory clinical outcome. In squamous cell carcinoma of the head and neck, the presence, activity, and also suppression of tumor-specific
62#
發(fā)表于 2025-4-1 07:16:33 | 只看該作者
Immunotherapy and Immunosurveillance of Oral Cancers: Perspectives of Plasma Medicine and Mistletoetime, a second tumor, located at the kidney, however remained unaffected. The main difference in treatment being peritumoral vs. systematic application supports the hypothesis of immunosurveillance. The impact of mistletoe extract in direct contact with the tumor tissue might be explained by targete
63#
發(fā)表于 2025-4-1 11:56:23 | 只看該作者
Immunopathology of Bone and Connective Tissue Cancers and Immunotherapy of Sarcomas, of the first forms of immunotherapy for the treatment of sarcoma. With advancements in molecular oncology and the identification of specific sarcoma antigens, direct experimentation has been made possible in a variety of preclinical animal models. Discoveries from the laboratory have led to novel i
64#
發(fā)表于 2025-4-1 16:18:23 | 只看該作者
65#
發(fā)表于 2025-4-1 19:52:33 | 只看該作者
Immunotherapy of Lung Tumors,nly in some countries. The recent campaigns aimed at cessation of smoking have dramatically reduced cardiovascular events in some European countries. However, lung cancer remains an elusive disease with not much improvement in overall survival despite neoadjuvant chemotherapy, making this tumor a di
66#
發(fā)表于 2025-4-1 23:57:44 | 只看該作者
67#
發(fā)表于 2025-4-2 03:42:13 | 只看該作者
68#
發(fā)表于 2025-4-2 08:05:42 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 06:59
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
巴塘县| 栖霞市| 东光县| 诸城市| 高要市| 旬邑县| 十堰市| 阳江市| 望谟县| 灵台县| 土默特左旗| 法库县| 闻喜县| 嘉定区| 竹溪县| 汨罗市| 南汇区| 泰来县| 沂水县| 全椒县| 富民县| 南汇区| 冀州市| 修武县| 江北区| 汝州市| 卓尼县| 明光市| 罗城| 秦皇岛市| 盖州市| 蒲城县| 开化县| 邯郸县| 名山县| 永平县| 长宁县| 台江县| 紫金县| 邵武市| 尖扎县|